Johnson & Johnson (JNJ)

EBITDA Growth

-31.47%

Quarterly · Period ending:

JNJ logo

JNJ EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-31.47%
JNJ Quarterly EBITDA YoY % (11.20% → -31.47%)
High-resolution chart · PNG

JNJ ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Johnson & Johnson EBITDA Growth — Quarterly
Period endingEBITDA Growth
16.2477%
13.2275%
11.8427%
3.9353%
9.9846%
13.8554%
8.0707%
6.5918%
22.2918%
20.5082%
22.7433%
28.861%
7.1093%
6.3023%
6.1605%
0.1934%
5%
9.2762%
11.9861%
3.5035%
31.3599%
22.356%
21.6102%
34.2742%
15.3682%
24.1195%
28.9617%
25.6757%
25.1001%
12.485%
9.1885%
11.9093%
1.4905%
5.0441%
7.8507%
0.7619%
14.0649%
7.8912%
3.6%
-9.1696%
14.311%
6.2139%
8.8534%
35.363%
7.197%
-71.046%
18.3849%
107.9133%
-75.9891%
4.3668%
-74.8161%
-13.0076%
10.3251%
13.9303%
16.67%
-11.7328%
11.833%
16.0307%
13.6758%
-8.9151%
11.1992%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.